Welcome to Dermbits! Watch short videos of KOLs answering your questions

thumbnail_dermbits-colorful.png

dermbits-colorful.png

Dermbits

MD, MPH

Topical roflumilast is indicated for patients 12 years and older. What is the significance of this as you think about topical treatment options for patients?

Psoriasis

You. So indeed, topical reflumolast has an indication right down to the age of twelve years. So twelve years and older patients with psoriasis is the current indication. And this is really remarkable in that when it comes to the younger age group, twelve to 18, or anything under 18, we really have very few options that have been studied or have a labeled indication for psoriasis. So we know that patients in that twelve to 18 range also have a high prevalence of psoriasis, and having a safe and efficacious topical treatment option for this population is really key. So in addition to our adults, being able to use topical reformulas for twelve to 18 is really advantageous and clinically remarkable to have that option all.

Topical roflumilast is indicated for patients 12 years and older. What is the significance of this as you think about topical treatment options for patients?

Related CME